Trimethoprim-induced hyperkalemia in renal transplant recipient

Trimethoprim-sulfamethoxazole (TMP-SMX) is an antimicrobial agent used in a variety of infections. Adverse reactions are more common in patients with AIDS but occasionally occur in immunocompetent patients. Renal toxicity is usually a hypersensitivity reaction to the sulfa component and manifests as interstitial nephritis or sulfa crystallization in the renal tubules. Reversible hyperkalemia is a rarely reported side effect of TMP-SMX therapy attributed to TMP inhibition of potassium secretion in the distal renal tubule in a manner similar to the potassium-sparing diuretic, amiloride. We report a case of hyperkalemia associated with TMP-SMX occurring in a 32-year-old renal transplant recipient with no other risk factors for hyperkalemia. He was treated with TMP-SMX (800 mg + 160 mg) two tablets QID for suspected pneumocystis jiroveci pneumonia. He developed severe hyperkalemia on day 9 posttherapy. Hyperkalemia reverted to normal with withdrawal of trimethoprim..

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Indian Journal of Transplantation - 12(2018), 2, Seite 149-151

Sprache:

Englisch

Beteiligte Personen:

Abhijeet S More [VerfasserIn]
Nilesh R Bhange [VerfasserIn]
Kshitija G Gadekar [VerfasserIn]
Sudhir G Kulkarni [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.ijtonline.in [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Hyperkalemia
Kidney transplant
Pneumocystis jiroveci pneumonia
Surgery
Trimethoprim

doi:

10.4103/ijot.ijot_4_18

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ020995628